新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

wbrady5 phase_i [34 articles]

最近 wbrady5 さんのライブラリに追加された論文の中から タグ phase_i. You can also see everyone's phase_i.
  • An optimization algorithm for designing phase I cancer clinical trials
    Contemporary Clinical Trials, Vol. 29, No. 2. (March 2008), pp. 102-108.
    by Hui Jiang, Yifan Liu, Zheng Su
    posted to algorithm_based_design clinical_trial phase_i by wbrady5 on 2008-03-05 16:30:06 as **
  • A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials
    Contemporary Clinical Trials, Vol. 26, No. 2. (April 2005), pp. 131-140.
    by Mithat Gonen
    posted to bayesian phase_i by wbrady5 on 2008-02-26 02:28:35 as **
  • Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed?
    J Clin Oncol, Vol. 19, No. 1. (1 January 2001), pp. 265-272.
    by Edward L Korn, Susan G Arbuck, James M Pluda, Richard Simon, Richard S Kaplan, Michaele C Christian
    posted to clinical_trial cytostatic phase_i phase_ii phase_iii by wbrady5 on 2008-02-22 15:01:50 as **
  • Optimal phase I dose-escalation trial designs in oncology - A simulation study
    Statistics in Medicine, Vol. 9999, No. 9999. (2007), n/a.
    by Oke Gerke, Harald Siedentop
    posted to clinical_trial phase_i simulation by wbrady5 on 2008-01-26 00:22:32 as **
  • Design and Analysis of Phase I Clinical Trials
    Biometrics, Vol. 45, No. 3. (1989), pp. 925-937.
    by Barry E Storer
    posted to clinical_trial phase_i by wbrady5 on 2008-01-17 22:28:02 as read
  • 3 + 3 != (Rolling) 6
    J Clin Oncol, Vol. 26, No. 2. (10 January 2008), pp. 170-171.
    by Christine Hartford, Samuel L Volchenboum, Susan L Cohn
    posted to clinical_trial editorial pediatric phase_i by wbrady5 on 2008-01-09 22:30:31 as **
  • Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design
    J Clin Oncol, Vol. 26, No. 2. (10 January 2008), pp. 190-195.
    by Jeffrey M Skolnik, Jeffrey S Barrett, Bhuvana Jayaraman, Dimple Patel, Peter C Adamson
    posted to ab_design clinical_trial pediatric phase_i by wbrady5 on 2008-01-09 22:29:45 as **
  • Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
    Biostat, Vol. 2, No. 2. (1 June 2001), pp. 203-215.
    by Yong Lin, Weichung J Shih
    posted to algorithm_based_design clinical_trial phase_i by wbrady5 on 2008-01-09 15:11:16 as read
  • An investigation of the traditional algorithm-based designs for phase 1 cancer clinical trials
    Drug Information Journal, Vol. 36 (2002), pp. 865-873.
    by S Kang, CW Ahn
    posted to ab_design algorithm_based_design clinical_trial phase_i by wbrady5 on 2008-01-09 15:08:25 as read
  • Phase I and Phase I/II Dose Finding Algorithms Using Continual Reassessment Method
    (2005), pp. 31-58.
    by John O'Quigley
    edited by John Crowley, Donna P Ankerst
    posted to clinical_trial continual_reassessment_method phase_i phase_ii by wbrady5 on 2008-01-08 16:54:15 as **
  • Accelerated titration designs for phase I clinical trials in oncology
    J. Natl. Cancer Inst., Vol. 89, No. 15. (6 August 1997), pp. 1138-1147.
    by R Simon, B Freidlin, L Rubinstein, SG Arbuck, J Collins, MC Christian
    posted to ab_design clinical_trial phase_i by wbrady5 on 2008-01-07 19:46:36 as read
  • Simulation as a design tool for phase I/II clinical trials: An example from bone marrow transplantation
    Controlled Clinical Trials, Vol. 15, No. 6. (December 1994), pp. 450-462.
    by Ted A Gooley, Paul J Martin, Lloyd D Fisher, Mary Pettinger
    posted to clinical_trial phase_i phase_ii simulation by wbrady5 on 2008-01-07 13:58:52 as **
  • A New Dose-Finding Design for Bivariate Outcomes
    Biometrics, Vol. 59, No. 4. (2003), pp. 1001-1007.
    by Anastasia Ivanova
    posted to bivariate clinical_trial phase_i by wbrady5 on 2008-01-04 22:08:03 as **
  • Two-Dimensional Dose Finding in Discrete Dose Space
    Biometrics, Vol. 61, No. 1. (March 2005), pp. 217-222.
    by Kai Wang, Anastasia Ivanova
    posted to bayesian combination_therapy continual_reassessment_method phase_i by wbrady5 on 2008-01-04 22:05:21 as **
  • Retrospective Analysis of Sequential Dose-Finding Designs
    Biometrics, Vol. 61, No. 3. (2005), pp. 749-756.
    by John O'Quigley
    posted to ab_design clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-04 22:01:02 as **
  • A Parallel Phase III Clinical Trial Design for Combination Therapies
    Biometrics, Vol. 63, No. 2. (June 2007), pp. 429-436.
    by Huang, Xuelin, Biswas, Swati, Oki, Yasuhiro, Issa, Jean-Pierre, Berry, A Donald
    posted to bayesian bivariate clinical_trial combination_therapy phase_i phase_ii toxicity by wbrady5 on 2008-01-04 21:59:15 as **
  • Bayesian Dose-Finding in Phase III Clinical Trials Using Toxicity and Efficacy Odds Ratios
    Biometrics, Vol. 62, No. 3. (September 2006), pp. 777-787.
    by Yin, Guosheng, Li, Yisheng, Ji, Yuan
    posted to adaptive bayesian bivariate clinical_trial phase_i by wbrady5 on 2008-01-04 21:51:07 as **
  • A Bayesian Approach to Jointly Modeling Toxicity and Biomarker Expression in a Phase I/II Dose-Finding Trial
    Biometrics, Vol. 61, No. 2. (June 2005), pp. 343-354.
    by B Nebiyou, Yu Shen
    posted to bayesian biomarker clinical_trial phase_i phase_ii toxicity by wbrady5 on 2008-01-04 21:46:56 as **
  • Sequential Designs for Phase I Clinical Trials with Late-Onset Toxicities
    Biometrics, Vol. 56, No. 4. (2000), pp. 1177-1182.
    by Ying K Cheung, Rick Chappell
    posted to clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-04 21:45:12 as read
  • Designs for Single- or Multiple-Agent Phase I Trials
    Biometrics, Vol. 60, No. 3. (2004), pp. 661-669.
    by Mark R Conaway, Stephanie Dunbar, Shyamal D Peddada
    posted to clinical_trial combination_therapy phase_i toxicity by wbrady5 on 2008-01-04 21:35:23 as **
  • Bayesian Optimal Designs for Phase I Clinical Trials
    Biometrics, Vol. 59, No. 3. (2003), pp. 591-600.
    by Linda M Haines, Inna Perevozskaya, William F Rosenberger
    posted to bayesian clinical_trial optimal_design phase_i by wbrady5 on 2008-01-04 21:33:54 as **
  • Dose-Finding with Two Agents in Phase I Oncology Trials
    Biometrics, Vol. 59, No. 3. (2003), pp. 487-496.
    by Peter F Thall, Randall E Millikan, Peter Mueller, Sang J Lee
    posted to bayesian clinical_trial combination_therapy phase_i toxicity by wbrady5 on 2008-01-04 21:31:11 as read
  • Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations
    Journal of Biopharmaceutical Statistics, Vol. 16, No. 5. (2006), pp. 623-638.
    by Peter F Thall, John D Cook, Elihu H Estey
    posted to bayesian bivariate clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-02 22:12:27 as **
  • An Evaluation of a Bayesian Method of Dose Escalation Based on Bivariate Binary Responses
    Journal of Biopharmaceutical Statistics, Vol. 14, No. 4. (2004), pp. 969-983.
    by John Whitehead, Yinghui Zhou, John Stevens, Graham Blakey
    posted to bayesian bivariate continual_reassessment_method phase_i by wbrady5 on 2008-01-02 22:09:55 as **
  • Three-dose-cohort designs in cancer phase I trials
    Statistics in Medicine, Vol. 9999, No. 9999. (2007), n/a.
    by Bo Huang, Rick Chappell
    posted to continual_reassessment_method multiple_dosing phase_i by wbrady5 on 2007-12-21 21:50:21 as **
  • Phase I Studies of Chemotherapeutic Agents in Cancer Patients: A Review of the Designs
    Journal of Biopharmaceutical Statistics, Vol. 16, No. 5. (2006), pp. 579-604.
    by Douglas M Potter
    posted to clinical_trial phase_i review by wbrady5 on 2007-12-21 19:46:24 as read
  • Another look at two phase I clinical trial designs
    Statistics in Medicine, Vol. 18, No. 20. (1999), pp. 2683-2690.
    by John O'Quigley
    posted to continual_reassessment_method phase_i up_and_down_design by wbrady5 on 2007-12-11 19:57:08 as read
  • Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo study
    Statistics in Medicine, Vol. 10, No. 11. (1991), pp. 1647-1664.
    by John O'Quigley, Sylvie Chevret
    posted to phase_i by wbrady5 on 2007-12-11 19:56:25 as **
  • AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP-AND-DOWN DESIGN IN A DOSE FINDING STUDY IN CANCER PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSES
    Statistics in Medicine, Vol. 14, No. 9. (1995), pp. 911-922.
    by Susanne Møller
    posted to continual_reassessment_method phase_i up_and_down_design by wbrady5 on 2007-12-11 19:53:56 as read
  • Some practical improvements in the continual reassessment method for phase I studies
    Statistics in Medicine, Vol. 14, No. 11. (1995), pp. 1149-1161.
    by Steven N Goodman, Marianna L Zahurak, Steven Piantadosi
    posted to continual_reassessment_method phase_i by wbrady5 on 2007-12-11 19:46:53 as read
  • Escalation, group and <I>A</I> + <I>B</I> designs for dose-finding trials
    Statistics in Medicine, Vol. 25, No. 21. (2006), pp. 3668-3678.
    by Anastasia Ivanova
    posted to ab_design phase_i by wbrady5 on 2007-12-11 19:31:52 as read
  • A non-parametric approach to the design and analysis of two-dimensional dose-finding trials
    Statistics in Medicine, Vol. 23, No. 12. (2004), pp. 1861-1870.
    by Anastasia Ivanova, Kai Wang
    posted to bivariate combination_therapy nonparametric phase_i toxicity by wbrady5 on 2007-12-11 18:50:11 as read
  • An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations
    Statistics in Medicine, Vol. 26, No. 11. (2007), pp. 2317-2330.
    by Sumithra J Mandrekar, Yue Cui, Daniel J Sargent
    posted to bivariate combination_therapy continuation-ratio_model efficacy phase_i toxicity by wbrady5 on 2007-12-11 18:48:20 as read
  • Optimal designs and limiting optimal designs for a trinomial response
    Journal of Statistical Planning and Inference, Vol. 126, No. 1. (1 November 2004), pp. 347-360.
    by Kelly, Kathryn Chaloner
    posted to bivariate continuation-ratio_model optimal_design phase_i phase_ii trinomial_responses by wbrady5 on 2007-10-29 20:25:42 as **
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/wbrady5/tag/phase_i

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.